×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Virus Outbreak | India | Vaccine

India OKs AstraZeneca and Locally-made COVID-19 Vaccines

India OKs AstraZeneca and Locally-made COVID-19 Vaccines

Sunday, 03 January 2021 01:00 AM

NEW DELHI (AP) — India has authorized two COVID-19 vaccines, paving the way for a huge inoculation program to stem the coronavirus pandemic in the world’s second most populous country.

India’s drugs regulator on Sunday gave an emergency authorization for the vaccines developed by Oxford University and U.K.-based drugmaker AstraZeneca and another developed by the Indian company Bharat Biotech.

The country’s initial immunization plan aims to vaccinate 300 million people — health care workers, front-line staff including police and those considered vulnerable due to their age or other diseases — by August 2021.

India, with nearly 1.4 billion people, is the second-worst affected by the coronavirus after the U.S., with over 10.3 million confirmed cases and 149,435 deaths, though its rate of infection has come down significantly from a mid-September peak.

© Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Asia
India has authorized two COVID-19 vaccines, paving the way for a huge inoculation program to stem the coronavirus pandemic in the world's second most populous country.India's drugs regulator on Sunday gave an emergency authorization for the vaccines developed by Oxford...
Virus Outbreak,India,Vaccine
128
2021-00-03
Sunday, 03 January 2021 01:00 AM
Newsmax Media, Inc.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved